250 related articles for article (PubMed ID: 27194552)
1. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
[TBL] [Abstract][Full Text] [Related]
2. The MELFO Study: A Multicenter, Prospective, Randomized Clinical Trial on the Effects of a Reduced Stage-Adjusted Follow-Up Schedule on Cutaneous Melanoma IB-IIC Patients-Results After 3 Years.
Deckers EA; Hoekstra-Weebers JEHM; Damude S; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2020 May; 27(5):1407-1417. PubMed ID: 31535302
[TBL] [Abstract][Full Text] [Related]
3. The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years.
Moncrieff MD; Underwood B; Garioch JJ; Heaton M; Patel N; Bastiaannet E; Hoekstra-Weebers JEHM; Hoekstra HJ
Ann Surg Oncol; 2020 Oct; 27(11):4109-4119. PubMed ID: 32623608
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
[TBL] [Abstract][Full Text] [Related]
6. ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Evaluating patient satisfaction and cost-effectiveness of a reduced follow-up schedule: study protocol of a randomized controlled trial.
Ezendam NPM; de Rooij BH; Kruitwagen RFPM; Creutzberg CL; van Loon I; Boll D; Vos MC; van de Poll-Franse LV
Trials; 2018 Apr; 19(1):227. PubMed ID: 29661218
[TBL] [Abstract][Full Text] [Related]
7. Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines.
Francken AB; Shaw HM; Accortt NA; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2007 Jun; 14(6):1924-33. PubMed ID: 17357855
[TBL] [Abstract][Full Text] [Related]
8. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma.
Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E; Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S
Br J Dermatol; 2019 May; 180(5):1190-1197. PubMed ID: 29876940
[TBL] [Abstract][Full Text] [Related]
10. Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.
Rychetnik L; McCaffery K; Morton RL; Thompson JF; Menzies SW; Irwig L
J Surg Oncol; 2013 Apr; 107(5):463-8. PubMed ID: 23090908
[TBL] [Abstract][Full Text] [Related]
11. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
[TBL] [Abstract][Full Text] [Related]
12. [Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up].
Francken AB; Thompson JF; Bastiaannet E; Hoekstra HJ
Ned Tijdschr Geneeskd; 2008 Mar; 152(10):557-62. PubMed ID: 18402322
[TBL] [Abstract][Full Text] [Related]
13. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
14. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
15. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
16. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
17. Patients' perspectives of long-term follow-up for localised cutaneous melanoma.
Morton RL; Rychetnik L; McCaffery K; Thompson JF; Irwig L
Eur J Surg Oncol; 2013 Mar; 39(3):297-303. PubMed ID: 23287820
[TBL] [Abstract][Full Text] [Related]
18. Follow-up practice in endometrial cancer and the association with patient and hospital characteristics: a study from the population-based PROFILES registry.
Nicolaije KA; Ezendam NP; Vos MC; Boll D; Pijnenborg JM; Kruitwagen RF; Lybeert ML; van de Poll-Franse LV
Gynecol Oncol; 2013 May; 129(2):324-31. PubMed ID: 23435365
[TBL] [Abstract][Full Text] [Related]
19. Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.
Murchie P; Masthoff J; Walter FM; Rahman K; Allan JL; Burrows N; Proby C; Lee AJ; Johnston M; Durrani A; Depasquale I; Brant B; Neilson A; Meredith F; Treweek S; Hall S; McDonald A
Trials; 2019 Jun; 20(1):318. PubMed ID: 31159849
[TBL] [Abstract][Full Text] [Related]
20. Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study): An International Phase III Randomized Clinical Trial.
Moncrieff MD; Bastiaannet E; Underwood B; Francken AB; Garioch J; Damude S; Heaton M; Deckers EA; Patel N; Hoekstra-Weebers JE; Hoekstra HJ
Ann Surg; 2022 Oct; 276(4):e208-e216. PubMed ID: 35866644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
